Breakingviews
Thursday, July 7, 2016
Breakingviews: Sanofi's contingency plan
The French drugmaker is including a special security as part of its sweetened $10 bln offer to buy Medivation. Rob Cyran and Jeffrey Goldfarb discuss the pitfalls of this so-called CVR.
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment